Home » Stocks » ABMC

American Bio Medica Corp. (ABMC)

Stock Price: $0.1799 USD -0.0101 (-5.32%)
Updated Feb 25, 2021 3:53 PM EST - Market closed
Market Cap 6.82M
Revenue (ttm) 4.25M
Net Income (ttm) -804,000
Shares Out 35.96M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 25
Last Price $0.1799
Previous Close $0.1900
Change ($) -0.0101
Change (%) -5.32%
Day's Open 0.1722
Day's Range 0.1710 - 0.1897
Day's Volume 462,317
52-Week Range 0.0575 - 1.24

News

There are no news available yet.

About ABMC

American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detect... [Read more...]

Industry
Diagnostics & Research
IPO Date
Dec 24, 1997
CEO
Melissa A. Waterhouse
Employees
42
Stock Exchange
OTCMKTS
Ticker Symbol
ABMC
Full Company Profile

Financial Performance

In 2019, ABMC's revenue was $3.66 million, a decrease of -5.60% compared to the previous year's $3.87 million. Losses were -$681,000, -33.75% less than in 2018.

Financial Statements